Tarina Fe 1/20 EQ®

(norethindrone acetate and ethinyl estradiol tablets, USP and ferrous fumarate tablets) 1 mg/20 mcg and 75 mg

Tarina Fe 1/20 EQ® is an AB-rated generic oral contraceptive.

Compares to

Gildess® Fe 1/20, Junel® Fe 1/20, Larin™ Fe 1/20, Microgestin® Fe 1/20, and Tarina® Fe 1/20

NDC#

50102-228-23

View Full Prescribing Information, Including Boxed Warning

Product Details

  • A progestogen-estrogen combination oral contraceptive.
  • Monophasic administration regimen
    • 21 light yellow to yellow tablets of norethindrone acetate and ethinyl estradiol tablets
    • 7 brown placebo tablets of ferrous fumarate to help ease administration
    • Combined in a 28-day tablet blister pack

Product Sheet

The Product Information Sheet features a summary of all relevant product information including Tarina Fe 1/20 EQ® (norethindrone acetate and ethinyl estradiol tablets, USP and ferrous fumarate tablets) 1 mg/20 mcg and 75 mg product details, product description, NDC number, and product features.

Download Now

Product Features:

  • Use of oral contraceptives may increase menstrual cycle regularity, decrease blood loss, and decrease incidence of both iron-deficiency anemia and dysmenorrhea
  • Oral contraceptives may decrease the incidence of functional ovarian cysts and ectopic pregnancies

Breakthrough bleeding and spotting are sometimes encountered in patients on oral contraceptives, especially during the first three months of use. Non-hormonal causes should be considered, and adequate diagnostic measures taken to rule out malignancy or pregnancy in the event of breakthrough bleeding. Some women may encounter post-pill amenorrhea or oligomenorrhea, especially when such a condition was preexistent.

It is recommended that for any patient who has missed two consecutive periods, pregnancy should be ruled out before continuing oral contraceptive use. If the patient has not adhered to the prescribed schedule, the possibility of pregnancy should be considered at the time of the first missed period. Oral contraceptive use should be discontinued if pregnancy is confirmed.

Common side effects of oral contraceptives include irregular vaginal bleeding or spotting, difficulty wearing contact lenses, fluid retention, darkening of the skin, changes in appetite, headache, nervousness, depression, dizziness, loss of scalp hair, rash, and vaginal infections.

The use of oral contraceptives is associated with increased risks of several serious conditions including myocardial infarction, thromboembolism, stroke, hepatic neoplasia, and gallbladder disease, although the risk of serious morbidity or mortality is very small in healthy women without underlying risk factors.

View Full Prescribing Information, Including Boxed Warning

Distributor & Ordering Info

Tarina Fe 1/20 EQ®

NDC#: 50102-228-23

Package Size: A Carton Containing 3 Pouches

Distributor Phone URL Order Number
AmerisourceBergen 1-610-727-7000 amerisourcebergen.com 10189488
ANDA 1-800-331-2632 (Ext. 74591) andanet.com 50102022823
ASD Healthcare 1-800-746-6273 asdhealthcare.com 52458
Cardinal Health 1-800-326-6457 cardinalhealth.com 5478524
McKesson 1-855-625-6285 mckesson.com 3559242
Morris & Dickson 1-888-376-7409 morrisdickson.com 392795
R & S Northeast 1-800-262-7770 rsnortheast.com 022823

Order Tarina Fe 1/20 EQ®
(norethindrone acetate and ethinyl estradiol tablets, USP and ferrous fumarate tablets)

Order Now



Contact Your
Afaxys Pharma
Account Manager

Contact Now



View All
Afaxys Pharma
Products

View Now